**Core Concept**
Status epilepticus is a medical emergency characterized by prolonged or recurrent seizures without full recovery of consciousness between episodes. The initial management involves administering antiepileptic medications to terminate seizures quickly and safely. The choice of medication is critical, as it can significantly impact patient outcomes.

**Why the Correct Answer is Right**
The initial management of status epilepticus typically involves administering benzodiazepines, such as lorazepam or midazolam, which act on the GABA_A receptor to enhance inhibitory neurotransmission and terminate seizures. Phenytoin is an antiepileptic medication that acts on voltage-gated sodium channels to reduce neuronal excitability, but it is not typically used as a first-line treatment for status epilepticus due to its slow onset of action and potential for cardiac side effects. Levetiracetam and valproate are also antiepileptic medications that can be used in the management of status epilepticus, especially in patients who are refractory to benzodiazepines.

**Why Each Wrong Option is Incorrect**
**Option A:** Lorazepam is a useful drug for the initial management of status epilepticus, as it has a rapid onset of action and can be administered intravenously.
**Option C:** Levetiracetam is an effective antiepileptic medication that can be used in the management of status epilepticus, especially in patients who are refractory to benzodiazepines.
**Option D:** Valproate is also a useful medication for the management of status epilepticus, as it has a broad spectrum of activity and can be used in various clinical scenarios.

**Clinical Pearl / High-Yield Fact**
In the initial management of status epilepticus, it's essential to administer antiepileptic medications as soon as possible, ideally within 10-15 minutes of seizure onset. This can significantly improve patient outcomes and reduce the risk of long-term neurological damage.

**Correct Answer:** D. Phenytoin is not typically used as a first-line treatment for status epilepticus due to its slow onset of action and potential for cardiac side effects.